This website londonlovesbusiness.com/astrazeneca-boosts-profits-with-new-medicines/ is currently offline. Cloudflare's Always Online™ shows a snapshot of this web page from the Internet Archive's Wayback Machine. To check for the live version, click Refresh.

AstraZeneca boosts profits with new medicines

by LLB Reporter July 25, 2019

written by LLB Reporter 25^th Jul 19 9:02 am

Pharmaceutical giant AstraZeneca has posted a 9% rise in operating profit to $1.6bn.

Pascal Soriot, Astra Zeneca’s chief executive, said: “The momentum generated last year continued into the first half, consolidating AstraZeneca’s return to growth based on the strength of our new medicines.

“Five of these new medicines are anticipated to be blockbusters this year, supporting sales across both oncology and biopharmaceuticals. Emerging Markets, the US and Japan all grew strongly, and we delivered an encouraging turnaround in Europe in the second quarter.”